» Articles » PMID: 39285426

Artemisinin Conferred Cytoprotection to Human Retinal Pigment Epithelial Cells Exposed to Amiodarone-induced Oxidative Insult by Activating the CaMKK2/AMPK/Nrf2 Pathway

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2024 Sep 16
PMID 39285426
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ocular toxicity is a severe adverse effect that limits the chronic clinical use of the antiarrhythmic drug amiodarone. Here, we aimed to evaluate the cytoprotective effect of artemisinin and explore the potential signalling pathways in human retinal pigment epithelial (RPE) cell cultures.

Methods: D407 cell cultures were exposed to amiodarone and the impact of artemisinin was evaluated. The key parameters included lactate dehydrogenase (LDH) release, intracellular reactive oxygen species (ROS) generation, and the mitochondrial membrane potential (MMP). We also assessed the protein levels of cleaved caspase-3, cleaved poly (ADP-ribose) polymerase (PARP), phosphorylated adenosine monophosphate-activated protein kinase (AMPK)ɑ (p-AMPK), calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2), and nuclear factor erythroid 2-related factor 2 (Nrf2).

Results: Artemisinin reduced the cytotoxicity induced by amiodarone, as reflected by decreased LDH release, ROS generation, and MMP disruption. Additionally, artemisinin increased p-AMPK, CaMKK2, and Nrf2 protein levels. Inhibition of AMPK, CaMKK2, or Nrf2 abolished the cytoprotective effect of artemisinin. AMPK activation and Nrf2 knockdown further supported its protective role.

Conclusions: Artemisinin protected RPE cells from amiodarone-induced damage via the CaMKK2/AMPK/Nrf2 pathway. The in vivo experiments in mice confirmed its efficacy in preventing retinal injury caused by amiodarone. These results suggest that an artemisinin-based eye formulation could be repurposed for treating amiodarone-induced ocular toxicity.

Citing Articles

Artemisinin alleviates cisplatin-induced damage in GC-1 spermatogonia through ER stress mechanisms.

Lee R, Lee W, Kim D, Park H Heliyon. 2025; 11(4):e42579.

PMID: 40034267 PMC: 11874544. DOI: 10.1016/j.heliyon.2025.e42579.

References
1.
Koenekoop R, Lopez I, den Hollander A, Allikmets R, Cremers F . Genetic testing for retinal dystrophies and dysfunctions: benefits, dilemmas and solutions. Clin Exp Ophthalmol. 2007; 35(5):473-85. DOI: 10.1111/j.1442-9071.2007.01534.x. View

2.
Kim S, Park J . Morin hydrate attenuates CSE-induced lipid accumulation, ER stress, and oxidative stress in RPE cells: implications for age-related macular degeneration. Free Radic Res. 2019; 53(8):865-874. DOI: 10.1080/10715762.2019.1637862. View

3.
Wang J, Li M, Geng Z, Khattak S, Ji X, Wu D . Role of Oxidative Stress in Retinal Disease and the Early Intervention Strategies: A Review. Oxid Med Cell Longev. 2022; 2022:7836828. PMC: 9586758. DOI: 10.1155/2022/7836828. View

4.
Fisher S, Lewis G, Linberg K, Verardo M . Cellular remodeling in mammalian retina: results from studies of experimental retinal detachment. Prog Retin Eye Res. 2005; 24(3):395-431. DOI: 10.1016/j.preteyeres.2004.10.004. View

5.
Sachdeva M, Cano M, Handa J . Nrf2 signaling is impaired in the aging RPE given an oxidative insult. Exp Eye Res. 2013; 119:111-4. PMC: 3946784. DOI: 10.1016/j.exer.2013.10.024. View